Filing Details

Accession Number:
0001246360-14-003019
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-19 17:28:09
Reporting Period:
2014-06-17
Filing Date:
2014-06-19
Accepted Time:
2014-06-19 17:28:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911326 Synageva Biopharma Corp GEVA Biological Products, (No Disgnostic Substances) (2836) 561808663
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1384243 D Barry Quart 33 Hayden Ave
Lexington MA 02421
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-17 1,000 $23.95 1,000 No 4 M Direct
Common Stock Disposition 2014-06-17 1,000 $90.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-06-17 1,000 $0.00 1,000 $23.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 2017-06-27 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014.
  2. The reporting person previously transferred an option to purchase 2,000 Shares of the original 4,000 granted under this stock option, which transfer was not previously reported as permitted under Rule 16a-12 of the Securities Exchange Act.
  3. The stock option granted the reporting person an option to purchase 4,000 Shares. These options vested one-third every year over a three-year period and became exercisable on the following schedule: 33.33% on June 27, 2008, 33.33% on June 27, 2009, 33.33% on June 27, 2010.